• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹腔灌洗和间皮细胞面积在预防包裹性腹膜硬化症中的作用及其预后意义。

The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis.

机构信息

Kidney Center, Shirasagi Hospital, Osaka, Japan.

出版信息

Perit Dial Int. 2010 May-Jun;30(3):343-52. doi: 10.3747/pdi.2008.00273. Epub 2010 Mar 25.

DOI:10.3747/pdi.2008.00273
PMID:20338969
Abstract

BACKGROUND

Severe peritoneal injury and encapsulating peritoneal sclerosis (EPS) as complications of long-term peritoneal dialysis (PD) are issues of concern. The usefulness of peritoneal lavage after withdrawal of PD and the risk factors for EPS have not been addressed until now. Little is known about mesothelial cell area (MCA) in the effluent as a marker of peritoneal injury. In the present study, we investigated the clinical significance of peritoneal lavage after PD withdrawal and tried to clarify the risk factors related to MCA, with the aim of preventing EPS. We also developed an algorithm for the clinical management of long-term PD patients.

METHODS

We assigned 247 PD patients to one of two cohorts after PD withdrawal: a non-lavage group (73 patients) and a lavage group (174 patients). To clarify the risk factors, we studied these potential predictors: PD duration, dialysate-to-plasma ratio of creatinine (D/P Cr) at the time of PD withdrawal, frequency of peritoneal lavage, type of PD or lavage solution, MCA at the time of PD withdrawal ("PD area"), and MCA at the time of peritoneal lavage withdrawal or censoring ("LA area"). Recurrent intestinal obstruction was defined as the main manifestation of EPS. Diagnostic performance and cut-off values were then calculated for the selected risk factors.

RESULTS

The overall incidence of EPS was significantly lower in the lavage group, at 6.9% (5.2% during lavage and 2.5% after lavage), than in the non-lavage group, at 15.1%. The risk factors and cut-off values were PD area (350 µm(2)) and PD duration (78 months) for the non-lavage group; and PD area (350 µm(2)) and LA area (320 µm(2)) for the lavage group. Patients with a PD duration of 78 months or more and a PD area of 350 µm(2) or more were defined as high-risk patients in the non-lavage group (risk ratio: 11.14), and patients with a PD area of 350 µm(2) or more and an LA area of 320 µm(2) or more were defined as high-risk patients in the lavage group (risk ratio: 10.43).

CONCLUSIONS

Peritoneal lavage is effective in reducing the incidence of EPS after PD withdrawal. The PD duration and MCA are significant risk factors, and these markers are useful for classifying patients into low- and high-risk groups for the development of EPS.

摘要

背景

长期腹膜透析(PD)导致的严重腹膜损伤和包裹性腹膜硬化症(EPS)是令人关注的问题。目前尚未研究 PD 停止后腹膜灌洗的作用,以及 EPS 的相关危险因素。尚不清楚灌洗流出液中间皮细胞面积(MCA)作为腹膜损伤的标志物的意义。本研究旨在探讨 PD 停止后腹膜灌洗的临床意义,并试图阐明与 MCA 相关的危险因素,以期预防 EPS。我们还开发了一种针对长期 PD 患者的临床管理算法。

方法

PD 停止后,我们将 247 名 PD 患者分为两组:非灌洗组(73 例)和灌洗组(174 例)。为了明确危险因素,我们研究了这些潜在的预测因素:PD 持续时间、PD 停止时的肌酐透析液-血浆比(D/P Cr)、腹膜灌洗频率、PD 类型或灌洗液、PD 停止时的 MCA(“PD 面积”)以及腹膜灌洗停止或随访时的 MCA(“LA 面积”)。复发性肠梗阻定义为 EPS 的主要表现。然后计算选定危险因素的诊断性能和截断值。

结果

灌洗组的总体 EPS 发生率明显低于非灌洗组(6.9%,灌洗时为 5.2%,灌洗后为 2.5%)。非灌洗组的危险因素和截断值为 PD 面积(350 µm²)和 PD 持续时间(78 个月);灌洗组的危险因素和截断值为 PD 面积(350 µm²)和 LA 面积(320 µm²)。PD 持续时间≥78 个月和 PD 面积≥350 µm²的患者被定义为非灌洗组的高危患者(风险比:11.14),PD 面积≥350 µm²和 LA 面积≥320 µm²的患者被定义为灌洗组的高危患者(风险比:10.43)。

结论

PD 停止后腹膜灌洗可有效降低 EPS 的发生率。PD 持续时间和 MCA 是重要的危险因素,这些标志物可用于将患者分为发生 EPS 的低危和高危人群。

相似文献

1
The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis.腹腔灌洗和间皮细胞面积在预防包裹性腹膜硬化症中的作用及其预后意义。
Perit Dial Int. 2010 May-Jun;30(3):343-52. doi: 10.3747/pdi.2008.00273. Epub 2010 Mar 25.
2
Risk factors for encapsulating peritoneal sclerosis in long-term peritoneal dialysis: a retrospective observational study.长期腹膜透析中包裹性腹膜硬化的危险因素:一项回顾性观察研究。
Ther Apher Dial. 2014 Feb;18(1):68-73. doi: 10.1111/1744-9987.12048. Epub 2013 Apr 17.
3
Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment.接受腹膜透析治疗患者发生包裹性腹膜硬化的危险因素。
Clin Exp Nephrol. 2005 Jun;9(2):148-52. doi: 10.1007/s10157-005-0349-8.
4
Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients.慢性腹膜透析患者发生严重腹膜硬化的危险因素。
Ren Fail. 2017 Nov;39(1):32-39. doi: 10.1080/0886022X.2016.1244075. Epub 2016 Oct 24.
5
The peritoneal sieving of sodium: a simple and powerful test to rule out the onset of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis.腹膜筛钠:一项简单而强大的测试,可排除腹膜透析患者发生包裹性腹膜硬化症。
J Nephrol. 2018 Feb;31(1):137-145. doi: 10.1007/s40620-016-0371-9. Epub 2016 Dec 24.
6
Encapsulating peritoneal sclerosis in an Italian center: thirty year experience.意大利一家中心的腹膜包裹性硬化症:三十年经验
J Nephrol. 2016 Apr;29(2):259-267. doi: 10.1007/s40620-015-0241-x. Epub 2015 Oct 31.
7
Risk factors for encapsulating peritoneal sclerosis: Analysis of a 36-year experience in a University Hospital.包裹性腹膜硬化的危险因素:一所大学医院36年经验分析
Nephrology (Carlton). 2017 Nov;22(11):907-912. doi: 10.1111/nep.12911.
8
Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children.儿童长期腹膜透析与包裹性腹膜硬化症。
Pediatr Nephrol. 2010 Jan;25(1):75-81. doi: 10.1007/s00467-008-0982-z.
9
Absence of Post-Transplantation Encapsulating Peritoneal Sclerosis after Relatively Short Exposure to Peritoneal Dialysis: Prospective Analysis Using Repeated Abdominal CT Scanning.短期腹膜透析后无移植后包裹性腹膜硬化:使用重复腹部CT扫描的前瞻性分析
Perit Dial Int. 2017 Jul-Aug;37(4):443-450. doi: 10.3747/pdi.2016.00238.
10
Clinical risk factors and outcomes of massive ascites accumulation after discontinuation of peritoneal dialysis.停止腹膜透析后大量腹水积聚的临床危险因素和转归。
Ren Fail. 2020 Nov;42(1):1-9. doi: 10.1080/0886022X.2019.1700804.

引用本文的文献

1
Predictors of encapsulated peritoneal sclerosis in patients undergoing peritoneal dialysis using neutral-pH dialysate.使用中性pH值透析液进行腹膜透析的患者发生包裹性腹膜硬化的预测因素。
Clin Exp Nephrol. 2025 Feb;29(2):212-220. doi: 10.1007/s10157-024-02565-9. Epub 2024 Oct 4.
2
Recommendations for pathological diagnosis on biopsy samples from peritoneal dialysis patients.腹膜透析患者活检样本的病理诊断建议。
Pleura Peritoneum. 2017 Mar 1;2(1):3-15. doi: 10.1515/pp-2016-0028. Epub 2017 Mar 17.
3
Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on.
恶性胸膜间皮瘤早期诊断和预后的生物标志物:探索仍在继续。
Cancers (Basel). 2018 Jun 15;10(6):203. doi: 10.3390/cancers10060203.
4
Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children.成人及儿童腹膜透析的肾脏协会临床实践指南
BMC Nephrol. 2017 Nov 16;18(1):333. doi: 10.1186/s12882-017-0687-2.
5
A case of encapsulating peritoneal sclerosis presented shortly after renal transplantation.一例包裹性腹膜硬化症在肾移植后不久出现。
CEN Case Rep. 2014 May;3(1):40-43. doi: 10.1007/s13730-013-0079-9. Epub 2013 Jun 14.
6
Risk factors for drainage-requiring ascites after refractory peritonitis in peritoneal dialysis patients.腹膜透析患者难治性腹膜炎后需引流腹水的危险因素。
Int Urol Nephrol. 2016 Oct;48(10):1721-30. doi: 10.1007/s11255-016-1376-y. Epub 2016 Aug 5.
7
Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients.血管内皮细胞损伤是长期腹膜透析患者发生包裹性腹膜硬化的重要因素。
PLoS One. 2016 Apr 27;11(4):e0154644. doi: 10.1371/journal.pone.0154644. eCollection 2016.
8
Overcoming the Underutilisation of Peritoneal Dialysis.克服腹膜透析利用不足的问题
Biomed Res Int. 2015;2015:431092. doi: 10.1155/2015/431092. Epub 2015 Nov 11.
9
Encapsulating peritoneal sclerosis in an Italian center: thirty year experience.意大利一家中心的腹膜包裹性硬化症:三十年经验
J Nephrol. 2016 Apr;29(2):259-267. doi: 10.1007/s40620-015-0241-x. Epub 2015 Oct 31.
10
Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury.血管内皮生长因子受体-3是改善甲基乙二醛诱导的腹膜损伤中净超滤的新靶点。
Lab Invest. 2015 Sep;95(9):1029-43. doi: 10.1038/labinvest.2015.87. Epub 2015 Jun 29.